Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy.
作者信息
Fujimura Taku, Kambayashi Yumi, Sato Yota, Tanita Kayo, Tono Hisayuki, Lyu Chunbing, Takahashi Toshiya, Hashimoto Akira, Aiba Setsuya
机构信息
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
出版信息
J Dermatol. 2019 Jul;46(7):e260. doi: 10.1111/1346-8138.14786. Epub 2019 Jan 23.
PMID:30672615
Abstract
摘要
Zotero 插件